Skip to content

Cold and Warm Water for Performance Recovery

A Randomized Controlled Trial to Evaluate the Effectiveness of Repeated Cold- and Warm Water Immersion on Performance Recovery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04902924
Enrollment
30
Registered
2021-05-26
Start date
2021-10-01
Completion date
2022-05-01
Last updated
2025-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

cold water immersion, warm water immersion, muscle damage, recovery

Brief summary

The overall aim of this study is, to evaluate the effectiveness of repeated cold- and warm water immersion on performance recovery after muscle damage.

Detailed description

Participants perform a muscle-damage protocol, which comprises 5x20 drop jumps. After the exercise protocol is finished, the participants will undergo one of three recovery interventions. Cold-water immersion, Warm-water immersion or the control-intervention. During the exercise protocol and the recovery intervention following parameters will be assessed: Blood oxygenation, Muscle oxygenation, heart-rate, skin temperature and core temperature. Then, performance recovery will be assessed during the following 72 hrs (in a 24 hrs interval). At each time-point, following measurements will be conducted: vertical-jump performance, maximum voluntary isometric contraction of the m.quadriceps femoris muscle, muscle swelling and delayed-onset of muscle soreness.

Interventions

BEHAVIORALrepeated cold water therapy

This information can be found the description of the experimental arm.

BEHAVIORALrepeated warm water therapy

This information can be found the description of the experimental arm.

OTHERcontrol

This information can be found the description of the experimental arm.

Sponsors

University of Applied Sciences and Arts of Southern Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

This study is a randomized controlled trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy participants * No surgeries * No previous injuries * Anticonceptiva allowed

Exclusion criteria

* Acute injuries or current pain situations * Cryophobia * Fear * Pregnancy * Raynaud syndrome * Medication intake

Design outcomes

Primary

MeasureTime frameDescription
Maximum Voluntary Isometric Contraction (N)baseline to 72 hoursmaximun voluntary isometric contraction of the knee extensor muscle will be assessed.
Delayed Onset of Muscle Soreness (DOMS)baseline to 72 hoursdelayed onset of muscle soreness will be measured using a 0-10 scale, where 0 indicated no soreness and 10 indicates maximum soreness of the knee extensor muscles
Muscle Swellingbaseline to 72 hoursswelling of the knee extensor muscle will be performed using a ultrasound device.
Creatine-kinase (U/l)baseline to 72 hoursusing a blood sample (6 ml), creatine-kinase will be assessed
Muscle Blood Oxygenationthrough recovery intervention up to 30 minutesMuscle oxygenation saturation (SmO2) of the knee extensor muscle will be measured using near-infrared spectroscopy device. Oxygenated haemoglobin (oxyHb), deoxygenated haemoglobin (deoxyHb) and total haemoglobin (TotHb) were assessed in arbitrary units and SmO2 was calculated as oxyHb/TotHb x 100 value (%)
Skin Temperature (°C)through recovery intervention up to 30 minutesSkin temperature will be measured using a near infrared thermography camera
Core Temperature (°C)through recovery intervention up to 30 minutescore temperature will be measured using temperature pill that will provide real time values from the gastrointestinal region

Countries

Switzerland

Participant flow

Participants by arm

ArmCount
Repeated Cold-water Immersion
In this arm, the participants undergo repeated cold water immersion at 10°C for 2 x 5 min. Between the immersion, a break will be conducted 2.5 min. Participants will be immersed up to the iliac crest repeated cold water therapy: This information can be found the description of the experimental arm.
10
Repeated Warm-water Immersion
In this arm, the participants undergo repeated warm water immersion at 40°C for 2 x 5 min. Between the immersion, a break will be conducted 2.5 min. Participants will be immersed up to the iliac crestParticipants will be immersed up to the iliac crest. repeated warm water therapy: This information can be found the description of the experimental arm.
10
Control
In this arm, the participants undergo the control intervention which comprises to remain seated for 12.5 min. The participants, that will perform the muscle damaging protocol under hypoxia will also be treated with the control condition. control: This information can be found the description of the experimental arm.
10
Total30

Baseline characteristics

CharacteristicRepeated Warm-water ImmersionControlRepeated Cold-water ImmersionTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
10 Participants10 Participants10 Participants30 Participants
Age, Continuous23.1 years
STANDARD_DEVIATION 3.6
23.1 years
STANDARD_DEVIATION 1.6
23.8 years
STANDARD_DEVIATION 3.3
23.3 years
STANDARD_DEVIATION 2.9
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Switzerland
10 participants10 participants10 participants30 participants
Sex: Female, Male
Female
10 Participants10 Participants10 Participants30 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 100 / 10
other
Total, other adverse events
0 / 100 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 100 / 10

Outcome results

Primary

Core Temperature (°C)

core temperature will be measured using temperature pill that will provide real time values from the gastrointestinal region

Time frame: through recovery intervention up to 30 minutes

ArmMeasureGroupValue (MEAN)Dispersion
Repeated Cold-water ImmersionCore Temperature (°C)BL37.1 degree CelsiusStandard Deviation 0.4
Repeated Cold-water ImmersionCore Temperature (°C)post Exercise38.5 degree CelsiusStandard Deviation 0.2
Repeated Cold-water ImmersionCore Temperature (°C)post Intervention37.9 degree CelsiusStandard Deviation 0.2
Repeated Cold-water ImmersionCore Temperature (°C)10 min37.6 degree CelsiusStandard Deviation 0.2
Repeated Cold-water ImmersionCore Temperature (°C)20 min37.3 degree CelsiusStandard Deviation 0.2
Repeated Cold-water ImmersionCore Temperature (°C)30 min37.2 degree CelsiusStandard Deviation 0.2
Repeated Warm-water ImmersionCore Temperature (°C)30 min37.5 degree CelsiusStandard Deviation 0.2
Repeated Warm-water ImmersionCore Temperature (°C)BL37.1 degree CelsiusStandard Deviation 0.2
Repeated Warm-water ImmersionCore Temperature (°C)10 min37.8 degree CelsiusStandard Deviation 0.2
Repeated Warm-water ImmersionCore Temperature (°C)20 min37.5 degree CelsiusStandard Deviation 0.2
Repeated Warm-water ImmersionCore Temperature (°C)post Exercise38.4 degree CelsiusStandard Deviation 0.3
Repeated Warm-water ImmersionCore Temperature (°C)post Intervention38.5 degree CelsiusStandard Deviation 0.3
ControlCore Temperature (°C)post Exercise38.3 degree CelsiusStandard Deviation 0.2
ControlCore Temperature (°C)post Intervention37.9 degree CelsiusStandard Deviation 0.3
ControlCore Temperature (°C)30 min37.2 degree CelsiusStandard Deviation 0.1
ControlCore Temperature (°C)10 min37.5 degree CelsiusStandard Deviation 0.2
ControlCore Temperature (°C)BL36.8 degree CelsiusStandard Deviation 0.4
ControlCore Temperature (°C)20 min37.3 degree CelsiusStandard Deviation 0.2
Primary

Creatine-kinase (U/l)

using a blood sample (6 ml), creatine-kinase will be assessed

Time frame: baseline to 72 hours

ArmMeasureGroupValue (MEAN)Dispersion
Repeated Cold-water ImmersionCreatine-kinase (U/l)48h335.4 U/lStandard Deviation 256.9
Repeated Cold-water ImmersionCreatine-kinase (U/l)24h573.5 U/lStandard Deviation 488.9
Repeated Cold-water ImmersionCreatine-kinase (U/l)BL111.0 U/lStandard Deviation 41.5
Repeated Cold-water ImmersionCreatine-kinase (U/l)72h205.9 U/lStandard Deviation 146.2
Repeated Warm-water ImmersionCreatine-kinase (U/l)72h314.3 U/lStandard Deviation 321.8
Repeated Warm-water ImmersionCreatine-kinase (U/l)BL214.3 U/lStandard Deviation 180.9
Repeated Warm-water ImmersionCreatine-kinase (U/l)24h820.6 U/lStandard Deviation 517.7
Repeated Warm-water ImmersionCreatine-kinase (U/l)48h441.2 U/lStandard Deviation 349.2
ControlCreatine-kinase (U/l)BL119.8 U/lStandard Deviation 50.2
ControlCreatine-kinase (U/l)72h191.4 U/lStandard Deviation 118.1
ControlCreatine-kinase (U/l)48h288.3 U/lStandard Deviation 200.9
ControlCreatine-kinase (U/l)24h455.0 U/lStandard Deviation 318.2
Primary

Delayed Onset of Muscle Soreness (DOMS)

delayed onset of muscle soreness will be measured using a 0-10 scale, where 0 indicated no soreness and 10 indicates maximum soreness of the knee extensor muscles

Time frame: baseline to 72 hours

ArmMeasureGroupValue (MEAN)Dispersion
Repeated Cold-water ImmersionDelayed Onset of Muscle Soreness (DOMS)BL0.1 units on a scaleStandard Deviation 0.1
Repeated Cold-water ImmersionDelayed Onset of Muscle Soreness (DOMS)24h6.3 units on a scaleStandard Deviation 2.6
Repeated Cold-water ImmersionDelayed Onset of Muscle Soreness (DOMS)48h5.0 units on a scaleStandard Deviation 2.8
Repeated Cold-water ImmersionDelayed Onset of Muscle Soreness (DOMS)72h2.9 units on a scaleStandard Deviation 2.6
Repeated Warm-water ImmersionDelayed Onset of Muscle Soreness (DOMS)72h4.6 units on a scaleStandard Deviation 3.1
Repeated Warm-water ImmersionDelayed Onset of Muscle Soreness (DOMS)BL0.1 units on a scaleStandard Deviation 0.1
Repeated Warm-water ImmersionDelayed Onset of Muscle Soreness (DOMS)48h5.9 units on a scaleStandard Deviation 3
Repeated Warm-water ImmersionDelayed Onset of Muscle Soreness (DOMS)24h6.1 units on a scaleStandard Deviation 2.5
ControlDelayed Onset of Muscle Soreness (DOMS)72h3.3 units on a scaleStandard Deviation 2.3
ControlDelayed Onset of Muscle Soreness (DOMS)24h6.3 units on a scaleStandard Deviation 2.7
ControlDelayed Onset of Muscle Soreness (DOMS)48h6.1 units on a scaleStandard Deviation 3.1
ControlDelayed Onset of Muscle Soreness (DOMS)BL0.1 units on a scaleStandard Deviation 0.1
Primary

Maximum Voluntary Isometric Contraction (N)

maximun voluntary isometric contraction of the knee extensor muscle will be assessed.

Time frame: baseline to 72 hours

ArmMeasureGroupValue (MEAN)Dispersion
Repeated Cold-water ImmersionMaximum Voluntary Isometric Contraction (N)BL54.8 NewtonStandard Deviation 14.9
Repeated Cold-water ImmersionMaximum Voluntary Isometric Contraction (N)24h33.8 NewtonStandard Deviation 13.9
Repeated Cold-water ImmersionMaximum Voluntary Isometric Contraction (N)48h41.8 NewtonStandard Deviation 16.4
Repeated Cold-water ImmersionMaximum Voluntary Isometric Contraction (N)72h45.0 NewtonStandard Deviation 17
Repeated Warm-water ImmersionMaximum Voluntary Isometric Contraction (N)72h54.5 NewtonStandard Deviation 11.8
Repeated Warm-water ImmersionMaximum Voluntary Isometric Contraction (N)BL65.8 NewtonStandard Deviation 11.6
Repeated Warm-water ImmersionMaximum Voluntary Isometric Contraction (N)48h47.9 NewtonStandard Deviation 10.3
Repeated Warm-water ImmersionMaximum Voluntary Isometric Contraction (N)24h41.1 NewtonStandard Deviation 11.4
ControlMaximum Voluntary Isometric Contraction (N)72h40.4 NewtonStandard Deviation 13.2
ControlMaximum Voluntary Isometric Contraction (N)24h29.3 NewtonStandard Deviation 8.7
ControlMaximum Voluntary Isometric Contraction (N)48h34.7 NewtonStandard Deviation 12.3
ControlMaximum Voluntary Isometric Contraction (N)BL52.2 NewtonStandard Deviation 14.1
Primary

Muscle Blood Oxygenation

Muscle oxygenation saturation (SmO2) of the knee extensor muscle will be measured using near-infrared spectroscopy device. Oxygenated haemoglobin (oxyHb), deoxygenated haemoglobin (deoxyHb) and total haemoglobin (TotHb) were assessed in arbitrary units and SmO2 was calculated as oxyHb/TotHb x 100 value (%)

Time frame: through recovery intervention up to 30 minutes

ArmMeasureGroupValue (MEAN)Dispersion
Repeated Cold-water ImmersionMuscle Blood Oxygenation30min64.4 percentage of muscle oxygen saturationStandard Deviation 6.4
Repeated Cold-water ImmersionMuscle Blood Oxygenation10min73.6 percentage of muscle oxygen saturationStandard Deviation 5.3
Repeated Cold-water ImmersionMuscle Blood OxygenationBL68.7 percentage of muscle oxygen saturationStandard Deviation 4.4
Repeated Cold-water ImmersionMuscle Blood Oxygenationpost exercise70.4 percentage of muscle oxygen saturationStandard Deviation 7.7
Repeated Cold-water ImmersionMuscle Blood Oxygenationpost Intervention76.6 percentage of muscle oxygen saturationStandard Deviation 5.8
Repeated Cold-water ImmersionMuscle Blood Oxygenation20min67.8 percentage of muscle oxygen saturationStandard Deviation 2.7
Repeated Warm-water ImmersionMuscle Blood Oxygenation20min74.7 percentage of muscle oxygen saturationStandard Deviation 3.2
Repeated Warm-water ImmersionMuscle Blood Oxygenationpost exercise71.1 percentage of muscle oxygen saturationStandard Deviation 7.1
Repeated Warm-water ImmersionMuscle Blood Oxygenationpost Intervention76.6 percentage of muscle oxygen saturationStandard Deviation 3.4
Repeated Warm-water ImmersionMuscle Blood Oxygenation10min75.5 percentage of muscle oxygen saturationStandard Deviation 5.1
Repeated Warm-water ImmersionMuscle Blood Oxygenation30min74.4 percentage of muscle oxygen saturationStandard Deviation 3.9
Repeated Warm-water ImmersionMuscle Blood OxygenationBL68.8 percentage of muscle oxygen saturationStandard Deviation 3.8
ControlMuscle Blood Oxygenation30min73.0 percentage of muscle oxygen saturationStandard Deviation 6.1
ControlMuscle Blood OxygenationBL70.0 percentage of muscle oxygen saturationStandard Deviation 3.7
ControlMuscle Blood Oxygenationpost exercise73.4 percentage of muscle oxygen saturationStandard Deviation 5.9
ControlMuscle Blood Oxygenation20min73.5 percentage of muscle oxygen saturationStandard Deviation 6.6
ControlMuscle Blood Oxygenation10min75.0 percentage of muscle oxygen saturationStandard Deviation 5.4
ControlMuscle Blood Oxygenationpost Intervention74.0 percentage of muscle oxygen saturationStandard Deviation 4.8
Primary

Muscle Swelling

swelling of the knee extensor muscle will be performed using a ultrasound device.

Time frame: baseline to 72 hours

ArmMeasureGroupValue (MEAN)Dispersion
Repeated Cold-water ImmersionMuscle SwellingBL4.3 cmStandard Deviation 0.5
Repeated Cold-water ImmersionMuscle Swelling24h4.6 cmStandard Deviation 0.5
Repeated Cold-water ImmersionMuscle Swelling48h4.5 cmStandard Deviation 0.5
Repeated Cold-water ImmersionMuscle Swelling72h4.4 cmStandard Deviation 0.5
Repeated Warm-water ImmersionMuscle Swelling72h5.0 cmStandard Deviation 0.6
Repeated Warm-water ImmersionMuscle SwellingBL4.8 cmStandard Deviation 0.6
Repeated Warm-water ImmersionMuscle Swelling48h5.1 cmStandard Deviation 0.5
Repeated Warm-water ImmersionMuscle Swelling24h5.2 cmStandard Deviation 0.6
ControlMuscle Swelling72h4.6 cmStandard Deviation 0.6
ControlMuscle Swelling24h4.8 cmStandard Deviation 0.6
ControlMuscle Swelling48h4.7 cmStandard Deviation 0.6
ControlMuscle SwellingBL4.6 cmStandard Deviation 0.5
Primary

Skin Temperature (°C)

Skin temperature will be measured using a near infrared thermography camera

Time frame: through recovery intervention up to 30 minutes

ArmMeasureGroupValue (MEAN)Dispersion
Repeated Cold-water ImmersionSkin Temperature (°C)BL30.6 degree CelsiusStandard Deviation 0.9
Repeated Cold-water ImmersionSkin Temperature (°C)post Exercise30.0 degree CelsiusStandard Deviation 0.9
Repeated Cold-water ImmersionSkin Temperature (°C)post Intervention15.2 degree CelsiusStandard Deviation 2.5
Repeated Cold-water ImmersionSkin Temperature (°C)10min24.8 degree CelsiusStandard Deviation 1.2
Repeated Cold-water ImmersionSkin Temperature (°C)20min27.9 degree CelsiusStandard Deviation 1.1
Repeated Cold-water ImmersionSkin Temperature (°C)30min29.2 degree CelsiusStandard Deviation 1
Repeated Warm-water ImmersionSkin Temperature (°C)30min34.8 degree CelsiusStandard Deviation 0.7
Repeated Warm-water ImmersionSkin Temperature (°C)BL31.2 degree CelsiusStandard Deviation 1.1
Repeated Warm-water ImmersionSkin Temperature (°C)10min35.3 degree CelsiusStandard Deviation 0.5
Repeated Warm-water ImmersionSkin Temperature (°C)20min34.9 degree CelsiusStandard Deviation 0.5
Repeated Warm-water ImmersionSkin Temperature (°C)post Exercise29.9 degree CelsiusStandard Deviation 1
Repeated Warm-water ImmersionSkin Temperature (°C)post Intervention35.2 degree CelsiusStandard Deviation 0.7
ControlSkin Temperature (°C)post Exercise29.5 degree CelsiusStandard Deviation 1.7
ControlSkin Temperature (°C)post Intervention31.8 degree CelsiusStandard Deviation 1
ControlSkin Temperature (°C)30min32.5 degree CelsiusStandard Deviation 0.9
ControlSkin Temperature (°C)10min32.3 degree CelsiusStandard Deviation 0.8
ControlSkin Temperature (°C)BL30.9 degree CelsiusStandard Deviation 0.9
ControlSkin Temperature (°C)20min32.4 degree CelsiusStandard Deviation 0.8

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026